Myriad Genetics (MYGN) Revenue Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) Revenue Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 22.77% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 0.91% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 0.01% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 8.22% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 2.24% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 4.36% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 42.30% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 0.12% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 0.66% |
| 10 | Myriad Genetics | 414.15 Mn | 289.75 Mn | 137.60 Mn | 3.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.41% |
| Dec 31, 2025 | 5.67% |
| Sep 30, 2025 | 9.56% |
| Jun 30, 2025 | 5.93% |
| Mar 31, 2025 | 5.91% |
| Dec 31, 2024 | 9.41% |
| Sep 30, 2024 | 8.43% |
| Jun 30, 2024 | 3.75% |
| Mar 31, 2024 | 5.32% |
| Dec 31, 2023 | -13.12% |
| Sep 30, 2023 | 9.74% |
| Jun 30, 2023 | 25.34% |
| Mar 31, 2023 | 3.38% |
| Dec 31, 2022 | -3.05% |
| Sep 30, 2022 | -5.66% |
| Jun 30, 2022 | -5.93% |
| Mar 31, 2022 | -8.69% |
| Dec 31, 2021 | -9.48% |
| Sep 30, 2021 | -6.14% |
| Jun 30, 2021 | -0.78% |